"Quetiapine Fumarate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A dibenzothiazepine and ANTIPSYCHOTIC AGENT that targets the SEROTONIN 5-HT2 RECEPTOR; HISTAMINE H1 RECEPTOR, adrenergic alpha1 and alpha2 receptors, as well as the DOPAMINE D1 RECEPTOR and DOPAMINE D2 RECEPTOR. It is used in the treatment of SCHIZOPHRENIA; BIPOLAR DISORDER and DEPRESSIVE DISORDER.
| Descriptor ID |
D000069348
|
| MeSH Number(s) |
D02.886.680.702.500.500 D03.633.300.276.500
|
| Concept/Terms |
Quetiapine Fumarate- Quetiapine Fumarate
- Fumarate, Quetiapine
- Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-, (E)-2-butenedioate (2:1) (salt)
ICI 204,636- ICI 204,636
- 204,636, ICI
- ICI-204636
- ICI204636
- ICI 204636
- 204636, ICI
Quetiapine- Quetiapine
- 2-(2-(4-dibenzo(b,f)(1,4)thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol
|
Below are MeSH descriptors whose meaning is more general than "Quetiapine Fumarate".
Below are MeSH descriptors whose meaning is more specific than "Quetiapine Fumarate".
This graph shows the total number of publications written about "Quetiapine Fumarate" by people in this website by year, and whether "Quetiapine Fumarate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 12 | 12 |
| 2003 | 0 | 10 | 10 |
| 2004 | 0 | 22 | 22 |
| 2005 | 0 | 36 | 36 |
| 2006 | 0 | 33 | 33 |
| 2007 | 0 | 35 | 35 |
| 2008 | 0 | 32 | 32 |
| 2009 | 0 | 40 | 40 |
| 2010 | 0 | 41 | 41 |
| 2011 | 0 | 30 | 30 |
| 2012 | 1 | 33 | 34 |
| 2013 | 1 | 50 | 51 |
| 2014 | 2 | 38 | 40 |
| 2015 | 13 | 26 | 39 |
| 2016 | 18 | 8 | 26 |
| 2017 | 23 | 10 | 33 |
| 2018 | 24 | 15 | 39 |
| 2019 | 7 | 2 | 9 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Quetiapine Fumarate" by people in Profiles.
-
Letter to the editor: Quetiapine safety in ICU delirium management among SARS-CoV-2-infected patients. J Psychosom Res. 2021 10; 149:110598.
-
Delirium triggered by COVID-19 vaccine in an elderly patient. Geriatr Gerontol Int. 2021 Jun; 21(6):540.
-
Quetiapine-Associated Pseudotumor Cerebri. Am J Ther. 2020 Sep/Oct; 27(5):e532-e534.
-
Association of Quetiapine Overuse Letters With Prescribing by Physician Peers of Targeted Recipients: A Secondary Analysis of a Randomized Clinical Trial. JAMA Psychiatry. 2019 10 01; 76(10):1094-1095.
-
Bipolar depression and suicidal ideation: Moderators and mediators of a complex relationship. J Affect Disord. 2019 12 01; 259:164-172.
-
In a Model of Neuroinflammation Designed to Mimic Delirium, Quetiapine Reduces Cortisol Secretion and Preserves Reversal Learning in the Attentional Set Shifting Task. J Neuroimmune Pharmacol. 2019 09; 14(3):383-390.
-
Mental health and cognitive function responses to quetiapine in patients with methamphetamine abuse under methadone maintenance treatment. J Affect Disord. 2019 05 15; 251:235-241.
-
Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA) Trial. J Am Acad Child Adolesc Psychiatry. 2019 11; 58(11):1062-1078.
-
Quetiapine Attenuates the Neuroinflammation and Executive Function Deficit in Streptozotocin-Induced Diabetic Mice. Mediators Inflamm. 2019; 2019:1236082.
-
Needs monitoring with quetiapine. Chin Med J (Engl). 2019 Jan 05; 132(1):113-114.